0 TSX Venture News - November 8, 2018Medcolcanna Agreement ExpiredOAKVILLE, Ontario, Nov. 08, 2018 (GLOBE NEWSWIRE) — Broadway Gold Mining Ltd. (“Broadway” or the “Company”) (TSX-V: BRD) (OTCQB: BDWYF): […]Read More
0 NYSE Companies - November 8, 2018SFFILM and Dolby Institute Announce First Film to Receive Dolby Atmos and Dolby Vision GrantInaugural Dolby Fellowship in Partnership with SFFILM Awarded to Michael Tyburski and Ben Nabors’ Film Palimpsest SAN FRANCISCO, Calif., Nov. […]Read More
0 NYSE Companies - November 8, 2018Globus Medical Reports Third Quarter 2018 ResultsAUDUBON, Pa., Nov. 08, 2018 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its […]Read More
0 NYSE Companies - November 8, 2018Hudson La Force Elected President and Chief Executive OfficerCOLUMBIA, Md., Nov. 08, 2018 (GLOBE NEWSWIRE) — W. R. Grace & Co. (NYSE: GRA) announced today that its Board […]Read More
0 NYSE Companies - November 8, 2018One Liberty Properties Reports Third Quarter 2018 ResultsGREAT NECK, N.Y., Nov. 08, 2018 (GLOBE NEWSWIRE) — One Liberty Properties, Inc. (NYSE: OLP), a real estate investment trust […]Read More
0 NYSE Companies - November 8, 2018UPS Board Announces Quarterly DividendATLANTA, Nov. 08, 2018 (GLOBE NEWSWIRE) — The UPS (NYSE: UPS) Board of Directors today declared a regular quarterly dividend […]Read More
0 NASDAQ Companies - November 8, 2018FONAR Announces 1st Quarter Financial Results For Fiscal 2019Income from Operations increased 16% to $5.5 million, for the quarter ended September 30, 2018, versus same quarter one year […]Read More
0 NASDAQ Companies - November 8, 2018Synaptics Reports Results for First Quarter Fiscal 2019Revenue of $417.6 million GAAP net income per diluted share of $0.11, an improvement of $0.90 versus the year ago […]Read More
0 NASDAQ Companies - November 8, 2018AnaptysBio Announces Third Quarter 2018 Financial Results and Provides Pipeline UpdatesReported positive top-line data from an interim analysis of its ongoing Phase 2a proof-of-concept clinical trial of etokimab in severe […]Read More
0 NASDAQ Companies - November 8, 2018Dentsply Sirona Reports Third Quarter 2018 Results; Announces Restructuring Plan to Drive Value-CreationReported Q3 revenues of $928.4 million, down 8.0% compared to prior year; constant currency decline1 of 5.9% Q3 2018 GAAP […]Read More